Membranoproliferative Glomerulonephritis
Symptoms, Doctors, Treatments, Advances & More

Learn About Membranoproliferative Glomerulonephritis

What is the definition of Membranoproliferative Glomerulonephritis?

Membranoproliferative glomerulonephritis is a kidney disorder that involves inflammation and changes to kidney cells. It may lead to kidney failure.

What are the alternative names for Membranoproliferative Glomerulonephritis?

Membranoproliferative GN I; Membranoproliferative GN II; Mesangiocapillary glomerulonephritis; Membranoproliferative glomerulonephritis; Lobular GN; Glomerulonephritis - membranoproliferative; MPGN type I; MPGN type II

What are the causes of Membranoproliferative Glomerulonephritis?

Glomerulonephritis is an inflammation of the glomeruli. The glomeruli of the kidney help filter wastes and fluids from the blood to form urine.

Membranoproliferative glomerulonephritis (MPGN) is a form of glomerulonephritis caused by an abnormal immune response. Deposits of antibodies build up in a part of the kidneys called the glomerular basement membrane. This membrane helps filter wastes and extra fluids from the blood.

Damage to this membrane affects the kidney's ability to create urine normally. It may allow blood and protein to leak into the urine. If enough protein leaks into the urine, fluid may leak out of the blood vessels into body tissues, leading to swelling (edema). Nitrogen waste products may also build up in the blood (azotemia).

The 2 forms of this disease are MPGN I and MPGN II.

Most people with the disease have type I. MPGN II is much less common. It also tends to get worse faster than MPGN I.

Causes of MPGN may include:

  • Autoimmune diseases (such as systemic lupus erythematosus, scleroderma, Sjögren syndrome, and sarcoidosis)
  • Cancer (leukemia, lymphoma)
  • Infections (hepatitis B, hepatitis C, endocarditis, malaria)
What are the symptoms of Membranoproliferative Glomerulonephritis?

Symptoms may include any of the following:

  • Blood in the urine
  • Changes in mental status such as decreased alertness or decreased concentration
  • Cloudy urine
  • Dark urine (smoke, cola, or tea colored)
  • Decrease in urine volume
  • Swelling of any part of the body
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Membranoproliferative Glomerulonephritis?

The treatment depends on the symptoms. The goals of treatment are to reduce symptoms, prevent complications, and slow the progression of the disorder.

You may need a change in diet. This may include limiting sodium, fluids, or protein to help control high blood pressure, swelling, and the buildup of waste products in the blood.

Medicines that may be prescribed include:

  • Blood pressure medicines
  • Dipyridamole, with or without aspirin
  • Diuretics
  • Medicines to suppress the immune system, such as cyclophosphamide
  • Steroids

Treatment is more effective in children than in adults. Dialysis or kidney transplant may eventually be needed to manage kidney failure.

Who are the top Membranoproliferative Glomerulonephritis Local Doctors?
Elite in Membranoproliferative Glomerulonephritis
Elite in Membranoproliferative Glomerulonephritis
Referral may be required

CUIMC/Herbert Irving Pavilion

161 Fort Washington Avenue, Floor 2, Suite 202, 
New York, NY 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Andrew Bomback is a Nephrologist practicing medicine in New York, New York. Dr. Bomback is rated as an Elite provider by MediFind in the treatment of Membranoproliferative Glomerulonephritis. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Membranoproliferative Glomerulonephritis, Glomerulonephritis, Membranous Nephropathy, Focal Segmental Glomerulosclerosis, and Kidney Transplant. Dr. Bomback is board certified in Internal Medicine and Nephrology. Dr. Bomback is currently accepting new patients.

Elite in Membranoproliferative Glomerulonephritis
Elite in Membranoproliferative Glomerulonephritis
Referral may be required
Madrid, MD, ES 

Manuel Praga practices practicing medicine in Madrid, Spain. Mr. Praga is rated as an Elite expert by MediFind in the treatment of Membranoproliferative Glomerulonephritis. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Membranoproliferative Glomerulonephritis, Glomerulonephritis, IgA Nephropathy, Kidney Transplant, and Tissue Biopsy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Membranoproliferative Glomerulonephritis
Elite in Membranoproliferative Glomerulonephritis
Referral may be required

Mayo Clinic-Rochester

200 1st St SW, 
Rochester, MN 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Fernando Fervenza is a Nephrologist practicing medicine in Rochester, Minnesota. Dr. Fervenza is rated as an Elite provider by MediFind in the treatment of Membranoproliferative Glomerulonephritis. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glomerulonephritis, Membranous Nephropathy, Membranoproliferative Glomerulonephritis, Kidney Transplant, and Bone Marrow Aspiration. Dr. Fervenza is currently accepting new patients.

What is the outlook (prognosis) for Membranoproliferative Glomerulonephritis?

The condition often slowly gets worse and eventually results in chronic kidney failure.

Half of people with this condition develop long-term (chronic) kidney failure within 10 years. This is more likely in those who have higher levels of protein in their urine.

What are the possible complications of Membranoproliferative Glomerulonephritis?

Complications that may result from this disease include:

  • Acute nephritic syndrome
  • Acute renal failure
  • Chronic kidney disease
When should I contact a medical professional for Membranoproliferative Glomerulonephritis?

Contact your provider if:

  • You have symptoms of this condition
  • Your symptoms get worse or do not go away
  • You develop new symptoms, including decreased urine output
How do I prevent Membranoproliferative Glomerulonephritis?

Preventing infections such as hepatitis or managing diseases such as lupus may help prevent MPGN.

What are the latest Membranoproliferative Glomerulonephritis Clinical Trials?
A Phase 2 Study to Assess ADX-038 in Chinese Adults With Complement-Mediated Kidney Disease

Summary: This is a Phase 2 study to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics of ADX-038 in adults with complement-mediated kidney diseases. The study will enroll Chinese adults with IgA nephropathy, complement 3 glomerulopathy (C3G) and immune complex membranoproliferative glomerulonephritis (IC-MPGN). The study will evaluate ADX-038 administered alone (Part A) and in combina...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy (C3G) or Primary Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN): A Multi-Country Study

Summary: The purpose of this study is to evaluate the effectiveness and safety of Pegcetacoplan in patients with C3G and primary IC-MPGN in the real-world setting. This study will also assess biomarkers not routinely measured in clinical practice. Results will support the long-term evaluation of the benefit-risk profile of pegcetacoplan in a broad patient population, informing clinical decision-making.

Who are the sources who wrote this article ?

Published Date: September 02, 2025
Published By: Walead Latif, MD, Nephrologist and Clinical Associate Professor, Rutgers Medical School, Newark, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Radhakrishnan J, Stokes MB. Glomerular disorders and nephrotic syndromes. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 107.

Saha MK, Pendergraft WF, Jennette JC, Falk RJ. Primary glomerular disease. In: Yu ASL, Chertow GM, Luyckx VA, Marsden PA, Skorecki K, Taal MW, eds. Brenner and Rector's The Kidney. 11th ed. Philadelphia, PA: Elsevier; 2020:chap 31.

Sethi S, De Vriese AS, Fervenza FC. Immunoglobulin-mediated glomerulonephritis with a membranoproliferative pattern of injury and cryoglobulinemic glomerulonephritis. In: Johnson RJ, Floege J, Tonelli M, eds. Comprehensive Clinical Nephrology. 7th ed. Philadelphia, PA: Elsevier; 2024:chap 22.